Last reviewed · How we verify
C. difficile vaccine formulation 1. (c-difficile-vaccine-formulation-1)
C. difficile vaccine formulation 1. (generic name: c-difficile-vaccine-formulation-1) is a Vaccine Vaccine drug developed by Pfizer Inc.. It is currently FDA-approved for Prevention of Clostridioides difficile infection in individuals 50 years of age and older.
C. difficile vaccine formulation 1 is being studied in a clinical trial (NCT05805826) for its safety and effects in healthy adults. The trial is focused on understanding the vaccine's impact on Clostridoides Difficile Associated Disease.
At a glance
| Generic name | c-difficile-vaccine-formulation-1 |
|---|---|
| Sponsor | Pfizer Inc. |
| Drug class | Vaccine |
| Target | Not specified |
| Modality | Vaccine |
| Phase | FDA-approved |
Approved indications
- Prevention of Clostridioides difficile infection in individuals 50 years of age and older
Common side effects
Drug interactions
- Warfarin
- Antacids
- Proton pump inhibitors
- H2 blockers
- Immunosuppressants
- Live vaccines
- Bacillus Calmette-Guérin (BCG) vaccine
- Typhoid vaccine
Key clinical trials
- To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- C. difficile vaccine formulation 1. CI brief — competitive landscape report
- C. difficile vaccine formulation 1. updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI
Frequently asked questions about C. difficile vaccine formulation 1.
What is C. difficile vaccine formulation 1.?
What is C. difficile vaccine formulation 1. used for?
Who makes C. difficile vaccine formulation 1.?
What is the generic name of C. difficile vaccine formulation 1.?
What drug class is C. difficile vaccine formulation 1. in?
What development phase is C. difficile vaccine formulation 1. in?
What does C. difficile vaccine formulation 1. target?
Related
- Drug class: All Vaccine drugs
- Target: All drugs targeting Not specified
- Manufacturer: Pfizer Inc. — full pipeline
- Indication: Drugs for Prevention of Clostridioides difficile infection in individuals 50 years of age and older
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing